Evidence map›Paper›PMID 39328154›Full record

SynthesisEuropean psychiatry : the journal of the Association of European Psychiatrists2024

Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review.

Antonio Melillo, Andrea Perrottelli, Edoardo Caporusso, Andrea Coltorti, Giulia Maria Giordano, Luigi Giuliani, Pasquale Pezzella, Paola Bucci, Armida Mucci, Silvana Galderisi and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in European psychiatry : the journal of the Association of European Psychiatrists, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Profiles of Individuals With Long COVID Reporting Persistent Cognitive Complaints.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Antonio MelilloWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0002-1477-7916
Andrea PerrottelliWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0001-7771-1845
Edoardo CaporussoWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0003-4980-0466
Andrea ColtortiWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.
Giulia Maria GiordanoWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.
Luigi GiulianiWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.
Pasquale PezzellaWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0002-8442-5385
Paola BucciWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.
Armida MucciWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0002-6195-9456
Silvana GalderisiWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0002-1592-7656
Mario MajWorld Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0001-8408-0711

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCognitive impairment (CI) is one of the most prevalent and burdensome consequences of COVID-19 infection, which can persist up to months or even years after remission of the infection. Current guidelines on post-COVID CI are based on available knowledge on treatments used for improving CI in other conditions. The current review aims to provide an updated overview of the existing evidence on the efficacy of treatments for post-COVID CI.

methodsA systematic literature search was conducted for studies published up to December 2023 using three databases (PubMed-Scopus-ProQuest). Controlled and noncontrolled trials, cohort studies, case series, and reports testing interventions on subjects with CI following COVID-19 infection were included.

resultsAfter screening 7790 articles, 29 studies were included. Multidisciplinary approaches, particularly those combining cognitive remediation interventions, physical exercise, and dietary and sleep support, may improve CI and address the different needs of individuals with post-COVID-19 condition. Cognitive remediation interventions can provide a safe, cost-effective option and may be tailored to deficits in specific cognitive domains. Noninvasive brain stimulation techniques and hyperbaric oxygen therapy showed mixed and preliminary results. Evidence for other interventions, including pharmacological ones, remains sparse. Challenges in interpreting existing evidence include heterogeneity in study designs, assessment tools, and recruitment criteria; lack of long-term follow-up; and under-characterization of samples in relation to confounding factors.

conclusionsFurther research, grounded on shared definitions of the post-COVID condition and on the accurate assessment of COVID-related CI, in well-defined study samples and with longer follow-ups, is crucial to address this significant unmet need.

Indexed as

Cognitive DysfunctionPost-Acute COVID-19 SyndromeHumanscognitive impairmentCOVID-19long COVIDrehabilitationtreatment

Identifiers

PMID39328154
PMCPMC11457117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.